ELISA for antiphosphatidylethanolamine antibody detection: High impact of assay buffer on results

Journal of Immunological Methods

Volumn 358, Issue 1-2, 2010, Pages 9-16

  Sanmarco, Marielle ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Antiphosphatidylethanolamine antibodies; Antiphospholipid antibodies; Assay buffers; Bovine serum; ELISA

Indexed keywords

BOVINE SERUM ALBUMIN; BUFFER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EGG YOLK; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; MALE; MICROTITER PLATE ASSAY; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; REFERENCE VALUE; SOYBEAN; STANDARDIZATION;

ADULT; ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASES; BUFFERS; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPIDS; MALE; MIDDLE AGED; PHOSPHATIDYLETHANOLAMINES; SERUM;

BOVINAE; ESCHERICHIA COLI; GLYCINE MAX;

EID: 77953292469     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.04.002     Document Type: Article

References (18)

1. Berard M., Boffa M.C. Influence of the phosphatidylethanolamine (PE) and bovine serum origins on anti-PE antibody detection by ELISA. Thromb. Res. 1997, 85:439.
2. Berard M., Chantome R., Marcelli A., Boffa M.C. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. J. Rheumatol. 1996, 23:1369.
3. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, I:307.
4. Drouvalakis K.A., Buchanan R.R. Microtitre plate and assay buffer alter detection of antiphosphatidylethanolamine antibodies in lupus anticoagulant positive plasma. Thromb. Res. 1999, 94:205.
5. Gris J.C., Quéré I., Sanmarco M., Boutiere B., Mercier E., Amiral J., Hubert A.M., Ripart-Neveu S., Hoffet M., Tailland M.L., Rousseau O., Monpeyroux F., Dauzat M., Sampol J., Daures J.P., Berlan J., Marès P. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early fœtal loss. Thromb. Haemost. 2000, 84:228.
6. Li, Z., Wells, C.W., North, P.E., Kumar, S., Duris, C.B., McIntyre, J.A., Zhao, M., 2009. Phosphatidylethanolamine at the Luminal Endothelial Surface: Implications in Hemostasis and Thrombotic Autoimmunity. Clin. Appl. Thromb. Hemost. http://doi:10.1177/1076029609350620.
7. McIntyre J.A., Wagenknecht D.R. Anti-phosphatidylethanolamine (aPE) antibodies: a survey. J. Autoimmun. 2000, 15:185.
8. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., Derksen R.H., de Groot P.G., Koike T., Meroni P.L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P.G., Krilis S.A. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J. Thromb. Haemost. 2006, 4:295.
9. Pellegrino N.M., Caccavo D. Variability in anticardiolipin antibody detection: role of nonspecific IgG binding and different microtiter plates. Clin. Appl. Thromb. Hemost. 2007, 13:404.
10. Reber G., Tremblet C., Bernard C., Mermillod B., de Moerloose P. Anticardiolipin antibodies and thrombosis: buffer's influence on the detection and quantitation of anticardiolipin antibody measured by ELISA. Thromb. Res. 1990, 57:215.
11. Reber G., Arvieux J., Comby E., Degenne D., de Moerloose P., Sanmarco M., Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hémostase et la Thrombose). Thromb. Haemost. 1995, 73:444.
12. Sanmarco M., Alessi M.C., Harle J.R., Sapin C., Aillaud M.F., Gentile S., Juhan-Vague I., Weiller P.J. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses. Thromb. Haemost. 2001, 85:800.
13. Sanmarco M., Gayet S., Alessi M.C., Audrain M., De Maistre E., Gris J.C., De Groot P.G., Hachulla E., Harle J.R., Sie P., Boffa M.C. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb. Haemost. 2007, 97:949.
14. Sugi T., McIntyre J.A. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995, 86:3083.
15. Sugi T., McIntyre J.A. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens. J. Autoimmun. 2001, 17:207.
16. Sugi T., Katsunuma J., Izumi S., McIntyre J.A., Makino T. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses. Fertil. Steril. 1999, 71:1060.
17. Sugi T., Matsubayashi H., Inomo A., Dan L., Makino T. Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss. Obstet. Gynaecol. Res. 2004, 30:326.
18. Tsutsumi A., Ichikawa K., Matsuura E., Sawada K.I., Koike T. Heterogeneous behavior of anti-beta2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with beta2-glycoprotein I. J. Rheumatol. 2000, 27:391.